Orchid Cellmark Acquires Strand's Paternity and Immigration Testing Business | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark said today that it has bought Strand Analytical Laboratories’ paternity and immigration DNA testing business unit for an undisclosed sum.

Indianapolis-based Strand provides forensic, medical, and paternity testing services.

This deal gives Orchid Cellmark Strand’s government paternity, private paternity, and immigration accounts, which last year had revenues of around $450,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.